Emmaus Life Sciences (EMMA) Receivables - Other (2020 - 2021)
Emmaus Life Sciences' Receivables - Other came in at $509,000 for Q2 2021, up 27.3% from the prior quarter.
Powered by 
Analysis
Emmaus Life Sciences (EMMA) Receivables - Other (2020 - 2021) Analysis & Trends
At the end of FY2020, Emmaus Life Sciences' Receivables - Other was $376,000.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,171.37 Bn | 1,139.96 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 645.23 Bn | 565.09 Bn | 17.30 Bn |
| 3 | AbbVie | 502.25 Bn | 475.37 Bn | 12.70 Bn |
| 4 | Merck | 361.34 Bn | 315.71 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.82 Bn | 266.81 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.91 Bn | 241.60 Bn | 12.86 Bn |
| 7 | Amgen | 242.39 Bn | 197.79 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.55 Bn | 167.74 Bn | 6.22 Bn |
| 9 | Pfizer | 172.05 Bn | 118.70 Bn | 10.94 Bn |
| 10 | Emmaus Life Sciences | 4.21 Mn | -2.09 Mn | 5.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | 509,000.00 |
| Mar 31, 2021 | 400,000.00 |
| Dec 31, 2020 | 376,000.00 |
API Access
Emmaus Life Sciences Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=EMMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "EMMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=EMMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();